Current Affairs - Technology - Discussion

Researchers from the Indian Institute of Science (IISc) have developed a novel metal-based nanozyme designed to prevent abnormal blood clotting. This breakthrough is particularly significant in addressing conditions such as Pulmonary Thromboembolism (PTE) and thrombosis associated with COVID-19. Nanozymes are artificial nanomaterials that mimic the activity of antioxidant enzymes to control reactive oxygen species (ROS), thereby helping to regulate platelet activity and prevent dangerous clot formations. The IISc team’s innovation could pave the way for advanced treatments in managing life-threatening clotting disorders.